ArticleBMC medical genomics2025
Identification and validation of the cellular senescence-associated molecular pattern and diagnostic markers for osteoporosis.
Article in BMC medical genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bioinformatic Screening of Key Regulatory Molecules and Mechanisms in Osteoporosis Based on Tryptophan Metabolism-Related Genes.International journal of general medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOsteoporosis is an age-related skeletal disorder with an increasing burden of osteoporotic fractures worldwide, it is urgent the identification of reliable molecular characteristics to prevent the progression of severe osteoporosis.
methodsTwo datasets were obtained from the Gene Expression Omnibus (GEO) to identify differentially expressed genes (DEGs) and selected the cellular senescence-related genes (SRGs). Consensus clustering analysis was performed based on differentially expressed SRGs (DE-SRGs). The functional enrichment and immune features between cellular senescence-related clusters were explored. Moreover, two machine learning algorithms were used to select the candidate biomarkers for osteoporotic diagnosis. Fifty-four clinical samples were collected and used to validate the expression levels of diagnostic biomarkers using qPCR.
resultsA total of 2,706 DEGs (1,587 upregulated and 1,119 downregulated) were identified in osteoporosis. Of these DEGs, 50 DE-SRGs were screened out for consensus clustering analysis and to select the diagnostic biomarkers for osteoporosis. Two clusters were identified that were associated with the aberrant immune cell infiltrating characteristics and immune-related biological functions. Based on random forest and support vector machine–recursive feature elimination (SVM-RFE) algorithms, PDPK1, TRIM28, and WWP1 were selected and validated as the potential diagnostic biomarkers in osteoporosis.
conclusionIn conclusion, we comprehensively discovered the cellular senescence-related characteristics and identified three crucial diagnostic biomarkers responsible for osteoporosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.